At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
saltother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Inflammatory and Vascular Response to Dietary Salt in Rheumatoid Arthritis
In Brief
A clinical study evaluating salt for Rheumatoid Arthritis. Completed, enrolled 18 participants across 1 site.
Detailed Summary
In this study investigators propose to address the following hypotheses: 1) Reduction in dietary sodium will decrease inflammation in patients with rheumatoid arthritis (RA). 2) Reduction in dietary sodium will decrease blood pressure in patients with RA. 3) Reduction in dietary sodium will decrease tissue sodium in patients with RA.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis
CountriesUnited States
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 2018
Enrollment StartJan 2020
Primary CompletionSep 2024
Study CompletionDec 2024
TodayJul 2026
First PostedAug 28, 2018
Enrollment StartJan 2, 2020
Primary CompletionSep 30, 2024
Study CompletionDec 30, 2024
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 7.8 years ago
Interventions
saltother
Participants will randomly eat a high salt diet for 8 weeks and a low salt diet for 8 weeks